Heart Rhythm Society (HRS)

The Heart Rhythm Society (HRS) is the primary U.S. medical society for electrophysiology (EP). The organization promotes education and advocacy for cardiac arrhythmia professionals and patients, including setting policy guidelines and offering expert consensus.

Heart Rhythm Society launches new group focused on EP advocacy
The new organization, Heart Rhythm Advocates, will urge federal policymakers to pass legislation and support actions that have a positive impact on the future of electrophysiology.
With AFib ablation on the rise, HRS highlights importance of proper EP training
Cardiac ablation techniques and technologies are constantly evolving. Only well-trained specialists should be performing these procedures, the Heart Rhythm Society said in a new policy statement.
LBBAP limits hospital readmissions after TAVR
Left bundle branch area pacing is associated with better long-term outcomes than traditional right ventricular pacing when patients require PPMI after TAVR, according to new research in Heart Rhythm.
What cardiologists should expect as U.S. healthcare payment models evolve
Cardiologist Dan Blumenthal, MD, MBA, explains how changes in Medicare payments will greatly impact cardiology in the years ahead. In just a few short years, the business side of cardiology could look substantially different than it does today.
Cardiology groups push for Medicare reform in face of ‘unsustainable’ payment cuts
Nearly 130 healthcare groups are urging Congress to pass legislation that would provide relief to U.S. physicians struggling to keep up with wave after wave of payment reductions.

HRS releases consensus statement on arrhythmogenic cardiomyopathy: 5 things to know

The Heart Rhythm Society issued a first-ever consensus statement on the evaluation, risk stratification and management of arrhythmogenic cardiomyopathy at its annual conference in San Francisco this spring.

May 13, 2019

Program chair previews HRS.19 highlights

The Heart Rhythm Society's 2019 scientific sessions will be held May 8-11 in San Francisco, a venue that enabled the program committee to tap into Silicon Valley’s expertise with digital health, emerging technology and innovation. HRS.19 Program Director Christine Albert, MD, MPH, gave Cardiovascular Business a preview of meeting highlights.

April 16, 2019

Patricia Blake named new CEO of Heart Rhythm Society

Patricia V. Blake will take over as CEO of the Heart Rhythm Society (HRS) next March, HRS leadership announced Oct. 26.

October 26, 2018

Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon

DUBLIN and MUNICH — August 28, 2018 — Medtronic plc (NYSE:MDT) today announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life, reduced symptoms from abnormal heart rhythms, and low incidence of reinterventions and repeat ablation procedures.

August 28, 2018

New Study Demonstrates Feasibility of Novel Mechanical Sensor in Medtronic Micra Transcatheter Pacing System to Detect Atrial Contractions and Restore AV Synchrony

DUBLIN and BOSTON — May 11, 2018 — Medtronic plc (NYSE:MDT) today announced new clinical study results demonstrating that an investigational algorithm, utilizing the accelerometer signal in the Micra(TM) Transcatheter Pacing System (TPS) may restore AV synchrony, improving cardiac function in patients with sinus rhythm and atrioventricular (AV) block.

May 14, 2018

AFib ablation outperforms drugs in CABANA trial

Catheter ablation was found to be superior to optimal drug therapy for the primary treatment of atrial fibrillation (AFib) in the randomized CABANA trial presented May 10 at the Heart Rhythm Society’s annual scientific sessions in Boston. However, there was a caveat.

May 11, 2018

Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation

DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc (NYSE: MDT) today announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance(TM) Cryoballoon to isolate the pulmonary veins in patients with symptomatic persistent atrial fibrillation (AF).

March 19, 2018

Heart Rhythm Society (HRS)

Heart Rhythm Society launches new group focused on EP advocacy

With AFib ablation on the rise, HRS highlights importance of proper EP training

LBBAP limits hospital readmissions after TAVR

What cardiologists should expect as U.S. healthcare payment models evolve

Cardiology groups push for Medicare reform in face of ‘unsustainable’ payment cuts